Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chek Meng Poh

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|March 29, 2020
Multiplex Screening Assay for Identifying Cytotoxic CD8<sup>+</sup> T Cell EpitopesChek Meng Poh, Jian Zheng, Rudragouda Channappanavar, et al.
Cellular Microbiology|December 28, 2017
Interferon regulatory factor 1 is essential for pathogenic CD8+ T cell migration and retention in the brain during experimental cerebral malariaSin Yee Gun, Carla Claser, Teck Hui Teo, et al.
EMBO Molecular Medicine|November 9, 2017
Co-infection with Chikungunya virus alters trafficking of pathogenic CD8<sup>+</sup> T cells into the brain and prevents <i>Plasmodium</i>-induced neuropathologyTeck-Hui Teo, Shanshan W Howland, Carla Claser, et al.
Cell Reports|December 10, 2013
PD-1 dependent exhaustion of CD8+ T cells drives chronic malariaJoshua M Horne-Debets, Rebecca Faleiro, Deshapriya S Karunarathne, et al.
Cancer Research Communications|May 8, 2024
B7-H3-Targeting Chimeric Antigen Receptors Epstein-Barr Virus-specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3-positive Solid TumorsSiok Ping Yeo, Lindsay Kua, Jin Wei Tan, et al.
Immunity|August 18, 2016
Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell ImmunityDeshapriya S Karunarathne, Joshua M Horne-Debets, Johnny X Huang, et al.
EMBO Molecular Medicine|May 7, 2021
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, et al.
Clinical & Translational Immunology|February 25, 2021
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variantCheryl Yi-Pin Lee, Siti Naqiah Amrun, Rhonda Sin-Ling Chee, et al.
Journal of Clinical Immunology|October 30, 2021
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant InfectionSiew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, et al.
Nature Communications|June 3, 2020
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patientsChek Meng Poh, Guillaume Carissimo, Bei Wang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|March 29, 2020
Multiplex Screening Assay for Identifying Cytotoxic CD8<sup>+</sup> T Cell EpitopesChek Meng Poh, Jian Zheng, Rudragouda Channappanavar, et al.
Cellular Microbiology|December 28, 2017
Interferon regulatory factor 1 is essential for pathogenic CD8+ T cell migration and retention in the brain during experimental cerebral malariaSin Yee Gun, Carla Claser, Teck Hui Teo, et al.
EMBO Molecular Medicine|November 9, 2017
Co-infection with Chikungunya virus alters trafficking of pathogenic CD8<sup>+</sup> T cells into the brain and prevents <i>Plasmodium</i>-induced neuropathologyTeck-Hui Teo, Shanshan W Howland, Carla Claser, et al.
Cell Reports|December 10, 2013
PD-1 dependent exhaustion of CD8+ T cells drives chronic malariaJoshua M Horne-Debets, Rebecca Faleiro, Deshapriya S Karunarathne, et al.
Cancer Research Communications|May 8, 2024
B7-H3-Targeting Chimeric Antigen Receptors Epstein-Barr Virus-specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3-positive Solid TumorsSiok Ping Yeo, Lindsay Kua, Jin Wei Tan, et al.
Immunity|August 18, 2016
Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell ImmunityDeshapriya S Karunarathne, Joshua M Horne-Debets, Johnny X Huang, et al.
EMBO Molecular Medicine|May 7, 2021
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, et al.
Clinical & Translational Immunology|February 25, 2021
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variantCheryl Yi-Pin Lee, Siti Naqiah Amrun, Rhonda Sin-Ling Chee, et al.
Journal of Clinical Immunology|October 30, 2021
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant InfectionSiew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, et al.
Nature Communications|June 3, 2020
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patientsChek Meng Poh, Guillaume Carissimo, Bei Wang, et al.
Pageof 3